Validation of DIGIROP- Birth and DIGIROP- Screen for the discovery of retinopathy of prematurity requiring treatment in preterm births in Saudi Arabia

References

1. 1.↵
   1. Fierson WM.

   Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2018; 142: e20183061.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Al Amro SA,
   2. Al Aql F,
   3. Al Hajar S,
   4. Al Dhibi H,
   5. Al Nemri A,
   6. Mousa A, et al.

   Practical guidelines for screening and treatment of retinopathy of prematurity in Saudi Arabia. Saudi J Ophthalmol 2018; 32: 222-226.

   OpenUrlPubMed
3. 3.↵
   1. Al Amro SA,
   2. Al Ghamdi SM,
   3. Abouammoh MA,
   4. Al Aql F,
   5. Ahmad K,
   6. Alsulaiman SM.

   Saudi Arabian retinopathy of prematurity national telemedicine program: achievements and challenges. Saudi J Ophthalmol 2022; 36: 278-282.

   OpenUrlPubMed
4. 4.↵
   1. Binenbaum G,
   2. Bell EF,
   3. Donohue P,
   4. Quinn G,
   5. Shaffer J,
   6. Tomlinson LA, et al.

   Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study. JAMA Ophthalmol 2018; 136: 1034-1040.

   OpenUrlPubMed
5. 5.↵
   1. Cao JH,
   2. Wagner BD,
   3. McCourt EA,
   4. Cerda A,
   5. Sillau S,
   6. Palestine A, et al.

   The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm. J AAPOS 2016; 20: 19-24.

   OpenUrlPubMed
6. 6.↵
   1. Eckert GU,
   2. Fortes Filho JB,
   3. Maia M,
   4. Procianoy RS.

   A predictive score for retinopathy of prematurity in very low birth weight preterm infants. Eye (Lond) 2012; 26: 400-406.

   OpenUrlPubMed
7. 7.
   1. Hellström A,
   2. Hård AL,
   3. Engström E,
   4. Niklasson A,
   5. Andersson E,
   6. Smith L, et al.

   Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics 2009; 123: e638-e645.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Löfqvist C,
   2. Andersson E,
   3. Sigurdsson J,
   4. Engström E,
   5. Hård AL,
   6. Niklasson A, et al.

   Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 2006; 124: 1711-1718.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Raffa LH,
   2. Alessa SK,
   3. Alamri AS,
   4. Malaikah RH.

   Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Saudi cohort of preterm infants. Saudi Med J 2020; 41: 622-627.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Raffa LH,
    2. Akeely OM,
    3. Alariefy SA,
    4. Alharbi FA,
    5. Alkhateeb MA,
    6. Khan MA.

    Retrospective validation of the Alexandria retinopathy of prematurity model in preterm infants in Saudi Arabia. J Clin Neonatol 2023; 12: 7-12.

    OpenUrl
11. 11.↵
    1. Raffa LH,
    2. Bugshan N,
    3. Aljuhani R,
    4. Alghoribi R,
    5. Alharbi A,
    6. Aljohani W.

    Retrospective validation of the postnatal growth and retinopathy of prematurity (G-ROP) criteria in a developing country. Niger J Clin Pract 2023; 26: 217-222.

    OpenUrlPubMed
12. 12.↵
    1. Pivodic A,
    2. Hård AL,
    3. Löfqvist C,
    4. Smith LEH,
    5. Wu C,
    6. Bründer MC, et al.

    Individual risk prediction for sight-threatening retinopathy of prematurity using birth characteristics. JAMA Ophthalmol 2020; 138: 21-29.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Pivodic A,
    2. Johansson H,
    3. Smith LEH,
    4. Hård AL,
    5. Löfqvist C,
    6. Yoder BA, et al.

    Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity. Br J Ophthalmol 2022; 106: 1573-1580.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Almeida AC,
    2. Borrego LM,
    3. Brízido M,
    4. de Figueiredo MB,
    5. Teixeira F,
    6. Coelho C, et al.

    DIGIROP efficacy for detecting treatment-requiring retinopathy of prematurity in a Portuguese cohort. Eye (Lond) 2022; 36: 463-469.

    OpenUrlPubMed
15. 15.↵
    1. Chen S,
    2. Wu R,
    3. Chen H,
    4. Ma W,
    5. Du S,
    6. Li C, et al.

    Validation of the DIGIROP-birth model in a Chinese cohort. BMC Ophthalmol 2021; 21: 236.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Pivodic A,
    2. E H Smith L,
    3. Hård AL,
    4. Löfqvist C,
    5. Almeida AC,
    6. Al-Hawasi A, et al.

    Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary Swedish cohort. Br J Ophthalmol 2023; 107: 1132-1138.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123: 991-999.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Mintz-Hittner HA,
    2. Kennedy KA,
    3. Chuang AZ.

    Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 364: 603-615.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Stahl A,
    2. Lepore D,
    3. Fielder A,
    4. Fleck B,
    5. Reynolds JD,
    6. Chiang MF, et al.

    Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet 2019; 394: 1551-1559.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Raffa L,
    2. Alamri A,
    3. Alosaimi A,
    4. Alessa S,
    5. Alharbi S,
    6. Ahmedhussain H, et al.

    Validation of 3 weight gain-based algorithms as a screening tool to detect retinopathy of prematurity: a multicenter study. Indian J Ophthalmol 2023; 71: 2555-2560.

    OpenUrlPubMed